Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Mineralys Therapeutics, Inc. (MLYS) Similar Stocks

261 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mineralys Therapeutics, Inc.
$678.70M
-6.33
-8.38%
5 Buy
0 Hold
0 Sell
Strong Buy
$31.25
Eton Pharmaceuticals
$90.17M
103.85
19.79%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ovid Therapeutics
$73.07M
-1.44
-71.23%
5 Buy
2 Hold
0 Sell
Moderate Buy
$2.84
Protagonist Therapeutics
$2.12B
14.74
84.37%
5 Buy
0 Hold
0 Sell
Strong Buy
$42.20
Cyclerion Therapeutics
$9.08M
-0.52
-0.30%

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
MLYS
Mineralys Therapeutics, Inc.
13.67
-1.10
-7.45%
ETON
Eton Pharmaceuticals
3.51
0.78
28.57%
OVID
Ovid Therapeutics
1.03
-2.47
-70.57%
PTGX
Protagonist Therapeutics
36.10
16.74
86.47%
CYCN
Cyclerion Therapeutics
3.35
0.19
6.01%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis